APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Immunoprecipitation (IP) Kit

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Immunoprecipitation (IP) Kit Market Analysis and Forecast 2026-2032

Report ID 174002130222 December 2025209 pages

Choose your research edition.

Industry ResearchImmunoprecipitation (IP) Kit Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunoprecipitation (IP) Kit Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Immunoprecipitation (IP) Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunoprecipitation (IP) Kit Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunoprecipitation (IP) Kit Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Immunoprecipitation (IP) Kit market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immunoprecipitation (IP) Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Immunoprecipitation (IP) Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Immunoprecipitation (IP) Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Immunoprecipitation (IP) Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Immunoprecipitation (IP) Kit include Abbkine Scientific Co., Ltd., Active Motif, CD Bioparticles, Cell Signaling Technology, Inc., Engibody Biotechnology, Inc., MyBiosource, Inc., Novus Biologicals, Proteintech Group, Inc. and Rockland Immunochemicals, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Immunoprecipitation (IP) Kit, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immunoprecipitation (IP) Kit, also provides the sales of main regions and countries. Of the upcoming market potential for Immunoprecipitation (IP) Kit, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunoprecipitation (IP) Kit sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immunoprecipitation (IP) Kit market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Immunoprecipitation (IP) Kit sales, projected growth trends, production technology, application and end-user industry.

Immunoprecipitation (IP) Kit Segment by Company

Abbkine Scientific Co., Ltd.

Active Motif

CD Bioparticles

Cell Signaling Technology, Inc.

Engibody Biotechnology, Inc.

MyBiosource, Inc.

Novus Biologicals

Proteintech Group, Inc.

Rockland Immunochemicals, Inc.

Sino Biological, Inc.

Takara Bio Inc.

Merck KGaA

ACE Biotechnology

Thermo Fisher Scientific (China) Co., Ltd.

Beyotime Biotech. Inc.

Shanghai Epizyme Biomedical Technology Co., Ltd

Beaver

Wuhan Dia-An Biotechnology Co., Ltd

Immunoprecipitation (IP) Kit Segment by Type

Protein A

Protein G

Immunoprecipitation (IP) Kit Segment by Application

Pharmaceuticals and Biotechnology

Hospital and Diagnostic Laboratory

Research Institute

Other

Immunoprecipitation (IP) Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunoprecipitation (IP) Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunoprecipitation (IP) Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunoprecipitation (IP) Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Immunoprecipitation (IP) Kit in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Immunoprecipitation (IP) Kit manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunoprecipitation (IP) Kit sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immunoprecipitation (IP) Kit Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Protein A Major Manufacturers Table 3. Protein G Major Manufacturers Table 4. Global Immunoprecipitation (IP) Kit Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceuticals and Biotechnology Major Manufacturers Table 6. Hospital and Diagnostic Laboratory Major Manufacturers Table 7. Research Institute Major Manufacturers Table 8. Other Major Manufacturers Table 9. Immunoprecipitation (IP) Kit Industry Trends Table 10. Immunoprecipitation (IP) Kit Industry Drivers Table 11. Immunoprecipitation (IP) Kit Industry Opportunities and Challenges Table 12. Immunoprecipitation (IP) Kit Industry Restraints Table 13. Global Immunoprecipitation (IP) Kit Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Immunoprecipitation (IP) Kit Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Immunoprecipitation (IP) Kit Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Immunoprecipitation (IP) Kit Revenue Market Share by Region (2021-2026) Table 17. Global Immunoprecipitation (IP) Kit Revenue Market Share by Region (2027-2032) Table 18. Global Immunoprecipitation (IP) Kit Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Immunoprecipitation (IP) Kit Sales by Region (2021-2026) & (k units) Table 20. Global Immunoprecipitation (IP) Kit Sales by Region (2027-2032) & (k units) Table 21. Global Immunoprecipitation (IP) Kit Sales Market Share by Region (2021-2026) Table 22. Global Immunoprecipitation (IP) Kit Sales Market Share by Region (2027-2032) Table 23. Global Immunoprecipitation (IP) Kit Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Immunoprecipitation (IP) Kit Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Immunoprecipitation (IP) Kit Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Immunoprecipitation (IP) Kit Sales Market Share by Manufacturers (2021-2026) Table 27. Global Immunoprecipitation (IP) Kit Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Immunoprecipitation (IP) Kit Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Immunoprecipitation (IP) Kit Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Immunoprecipitation (IP) Kit Manufacturers, Product Type & Application Table 31. Global Immunoprecipitation (IP) Kit Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Immunoprecipitation (IP) Kit by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Immunoprecipitation (IP) Kit Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Immunoprecipitation (IP) Kit Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Immunoprecipitation (IP) Kit Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Immunoprecipitation (IP) Kit Revenue Market Share by Type (2021-2026) Table 38. Global Immunoprecipitation (IP) Kit Revenue Market Share by Type (2027-2032) Table 39. Global Immunoprecipitation (IP) Kit Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 41. Global Immunoprecipitation (IP) Kit Sales by Type (2027-2032) & (k units) Table 42. Global Immunoprecipitation (IP) Kit Sales Market Share by Type (2021-2026) Table 43. Global Immunoprecipitation (IP) Kit Sales Market Share by Type (2027-2032) Table 44. Global Immunoprecipitation (IP) Kit Price by Type (2021-2026) & (US$/unit) Table 45. Global Immunoprecipitation (IP) Kit Price by Type (2027-2032) & (US$/unit) Table 46. Global Immunoprecipitation (IP) Kit Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Immunoprecipitation (IP) Kit Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Immunoprecipitation (IP) Kit Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Immunoprecipitation (IP) Kit Revenue Market Share by Application (2021-2026) Table 50. Global Immunoprecipitation (IP) Kit Revenue Market Share by Application (2027-2032) Table 51. Global Immunoprecipitation (IP) Kit Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 53. Global Immunoprecipitation (IP) Kit Sales by Application (2027-2032) & (k units) Table 54. Global Immunoprecipitation (IP) Kit Sales Market Share by Application (2021-2026) Table 55. Global Immunoprecipitation (IP) Kit Sales Market Share by Application (2027-2032) Table 56. Global Immunoprecipitation (IP) Kit Price by Application (2021-2026) & (US$/unit) Table 57. Global Immunoprecipitation (IP) Kit Price by Application (2027-2032) & (US$/unit) Table 58. Abbkine Scientific Co., Ltd. Company Information Table 59. Abbkine Scientific Co., Ltd. Business Overview Table 60. Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio Table 62. Abbkine Scientific Co., Ltd. Recent Development Table 63. Active Motif Company Information Table 64. Active Motif Business Overview Table 65. Active Motif Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Active Motif Immunoprecipitation (IP) Kit Product Portfolio Table 67. Active Motif Recent Development Table 68. CD Bioparticles Company Information Table 69. CD Bioparticles Business Overview Table 70. CD Bioparticles Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. CD Bioparticles Immunoprecipitation (IP) Kit Product Portfolio Table 72. CD Bioparticles Recent Development Table 73. Cell Signaling Technology, Inc. Company Information Table 74. Cell Signaling Technology, Inc. Business Overview Table 75. Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 77. Cell Signaling Technology, Inc. Recent Development Table 78. Engibody Biotechnology, Inc. Company Information Table 79. Engibody Biotechnology, Inc. Business Overview Table 80. Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 82. Engibody Biotechnology, Inc. Recent Development Table 83. MyBiosource, Inc. Company Information Table 84. MyBiosource, Inc. Business Overview Table 85. MyBiosource, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. MyBiosource, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 87. MyBiosource, Inc. Recent Development Table 88. Novus Biologicals Company Information Table 89. Novus Biologicals Business Overview Table 90. Novus Biologicals Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Novus Biologicals Immunoprecipitation (IP) Kit Product Portfolio Table 92. Novus Biologicals Recent Development Table 93. Proteintech Group, Inc. Company Information Table 94. Proteintech Group, Inc. Business Overview Table 95. Proteintech Group, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Proteintech Group, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 97. Proteintech Group, Inc. Recent Development Table 98. Rockland Immunochemicals, Inc. Company Information Table 99. Rockland Immunochemicals, Inc. Business Overview Table 100. Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 102. Rockland Immunochemicals, Inc. Recent Development Table 103. Sino Biological, Inc. Company Information Table 104. Sino Biological, Inc. Business Overview Table 105. Sino Biological, Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Sino Biological, Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 107. Sino Biological, Inc. Recent Development Table 108. Takara Bio Inc. Company Information Table 109. Takara Bio Inc. Business Overview Table 110. Takara Bio Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Takara Bio Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 112. Takara Bio Inc. Recent Development Table 113. Merck KGaA Company Information Table 114. Merck KGaA Business Overview Table 115. Merck KGaA Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Merck KGaA Immunoprecipitation (IP) Kit Product Portfolio Table 117. Merck KGaA Recent Development Table 118. ACE Biotechnology Company Information Table 119. ACE Biotechnology Business Overview Table 120. ACE Biotechnology Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. ACE Biotechnology Immunoprecipitation (IP) Kit Product Portfolio Table 122. ACE Biotechnology Recent Development Table 123. Thermo Fisher Scientific (China) Co., Ltd. Company Information Table 124. Thermo Fisher Scientific (China) Co., Ltd. Business Overview Table 125. Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio Table 127. Thermo Fisher Scientific (China) Co., Ltd. Recent Development Table 128. Beyotime Biotech. Inc. Company Information Table 129. Beyotime Biotech. Inc. Business Overview Table 130. Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Product Portfolio Table 132. Beyotime Biotech. Inc. Recent Development Table 133. Shanghai Epizyme Biomedical Technology Co., Ltd Company Information Table 134. Shanghai Epizyme Biomedical Technology Co., Ltd Business Overview Table 135. Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio Table 137. Shanghai Epizyme Biomedical Technology Co., Ltd Recent Development Table 138. Beaver Company Information Table 139. Beaver Business Overview Table 140. Beaver Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Beaver Immunoprecipitation (IP) Kit Product Portfolio Table 142. Beaver Recent Development Table 143. Wuhan Dia-An Biotechnology Co., Ltd Company Information Table 144. Wuhan Dia-An Biotechnology Co., Ltd Business Overview Table 145. Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio Table 147. Wuhan Dia-An Biotechnology Co., Ltd Recent Development Table 148. North America Immunoprecipitation (IP) Kit Revenue by Type (2021-2026) & (US$ Million) Table 149. North America Immunoprecipitation (IP) Kit Revenue by Type (2027-2032) & (US$ Million) Table 150. North America Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 151. North America Immunoprecipitation (IP) Kit Sales by Type (2027-2032) & (k units) Table 152. North America Immunoprecipitation (IP) Kit Sales Price by Type (2021-2026) & (US$/unit) Table 153. North America Immunoprecipitation (IP) Kit Sales Price by Type (2027-2032) & (US$/unit) Table 154. North America Immunoprecipitation (IP) Kit Revenue by Application (2021-2026) & (US$ Million) Table 155. North America Immunoprecipitation (IP) Kit Revenue by Application (2027-2032) & (US$ Million) Table 156. North America Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 157. North America Immunoprecipitation (IP) Kit Sales by Application (2027-2032) & (k units) Table 158. North America Immunoprecipitation (IP) Kit Sales Price by Application (2021-2026) & (US$/unit) Table 159. North America Immunoprecipitation (IP) Kit Sales Price by Application (2027-2032) & (US$/unit) Table 160. North America Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. North America Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. North America Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. North America Immunoprecipitation (IP) Kit Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 164. North America Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 165. North America Immunoprecipitation (IP) Kit Sales by Country (2027-2032) & (k units) Table 166. North America Immunoprecipitation (IP) Kit Sales Price by Country (2021-2026) & (US$/unit) Table 167. North America Immunoprecipitation (IP) Kit Sales Price by Country (2027-2032) & (US$/unit) Table 168. United States Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 169. Canada Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 170. Mexico Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 171. Europe Immunoprecipitation (IP) Kit Revenue by Type (2021-2026) & (US$ Million) Table 172. Europe Immunoprecipitation (IP) Kit Revenue by Type (2027-2032) & (US$ Million) Table 173. Europe Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 174. Europe Immunoprecipitation (IP) Kit Sales by Type (2027-2032) & (k units) Table 175. Europe Immunoprecipitation (IP) Kit Sales Price by Type (2021-2026) & (US$/unit) Table 176. Europe Immunoprecipitation (IP) Kit Sales Price by Type (2027-2032) & (US$/unit) Table 177. Europe Immunoprecipitation (IP) Kit Revenue by Application (2021-2026) & (US$ Million) Table 178. Europe Immunoprecipitation (IP) Kit Revenue by Application (2027-2032) & (US$ Million) Table 179. Europe Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 180. Europe Immunoprecipitation (IP) Kit Sales by Application (2027-2032) & (k units) Table 181. Europe Immunoprecipitation (IP) Kit Sales Price by Application (2021-2026) & (US$/unit) Table 182. Europe Immunoprecipitation (IP) Kit Sales Price by Application (2027-2032) & (US$/unit) Table 183. Europe Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Europe Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Europe Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Europe Immunoprecipitation (IP) Kit Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 187. Europe Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 188. Europe Immunoprecipitation (IP) Kit Sales by Country (2027-2032) & (k units) Table 189. Europe Immunoprecipitation (IP) Kit Sales Price by Country (2021-2026) & (US$/unit) Table 190. Europe Immunoprecipitation (IP) Kit Sales Price by Country (2027-2032) & (US$/unit) Table 191. Germany Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 192. France Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 193. U.K. Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 194. Italy Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 195. Russia Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 196. Spain Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 197. Netherlands Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 198. Switzerland Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 199. Sweden Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 200. Poland Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 201. China Immunoprecipitation (IP) Kit Revenue by Type (2021-2026) & (US$ Million) Table 202. China Immunoprecipitation (IP) Kit Revenue by Type (2027-2032) & (US$ Million) Table 203. China Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 204. China Immunoprecipitation (IP) Kit Sales by Type (2027-2032) & (k units) Table 205. China Immunoprecipitation (IP) Kit Sales Price by Type (2021-2026) & (US$/unit) Table 206. China Immunoprecipitation (IP) Kit Sales Price by Type (2027-2032) & (US$/unit) Table 207. China Immunoprecipitation (IP) Kit Revenue by Application (2021-2026) & (US$ Million) Table 208. China Immunoprecipitation (IP) Kit Revenue by Application (2027-2032) & (US$ Million) Table 209. China Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 210. China Immunoprecipitation (IP) Kit Sales by Application (2027-2032) & (k units) Table 211. China Immunoprecipitation (IP) Kit Sales Price by Application (2021-2026) & (US$/unit) Table 212. China Immunoprecipitation (IP) Kit Sales Price by Application (2027-2032) & (US$/unit) Table 213. Asia Immunoprecipitation (IP) Kit Revenue by Type (2021-2026) & (US$ Million) Table 214. Asia Immunoprecipitation (IP) Kit Revenue by Type (2027-2032) & (US$ Million) Table 215. Asia Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 216. Asia Immunoprecipitation (IP) Kit Sales by Type (2027-2032) & (k units) Table 217. Asia Immunoprecipitation (IP) Kit Sales Price by Type (2021-2026) & (US$/unit) Table 218. Asia Immunoprecipitation (IP) Kit Sales Price by Type (2027-2032) & (US$/unit) Table 219. Asia Immunoprecipitation (IP) Kit Revenue by Application (2021-2026) & (US$ Million) Table 220. Asia Immunoprecipitation (IP) Kit Revenue by Application (2027-2032) & (US$ Million) Table 221. Asia Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 222. Asia Immunoprecipitation (IP) Kit Sales by Application (2027-2032) & (k units) Table 223. Asia Immunoprecipitation (IP) Kit Sales Price by Application (2021-2026) & (US$/unit) Table 224. Asia Immunoprecipitation (IP) Kit Sales Price by Application (2027-2032) & (US$/unit) Table 225. Asia Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. Asia Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. Asia Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. Asia Immunoprecipitation (IP) Kit Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 229. Asia Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 230. Asia Immunoprecipitation (IP) Kit Sales by Country (2027-2032) & (k units) Table 231. Asia Immunoprecipitation (IP) Kit Sales Price by Country (2021-2026) & (US$/unit) Table 232. Asia Immunoprecipitation (IP) Kit Sales Price by Country (2027-2032) & (US$/unit) Table 233. Japan Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 234. South Korea Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 235. India Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 236. Australia Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 237. Taiwan Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 238. Southeast Asia Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 239. SAMEA Immunoprecipitation (IP) Kit Revenue by Type (2021-2026) & (US$ Million) Table 240. SAMEA Immunoprecipitation (IP) Kit Revenue by Type (2027-2032) & (US$ Million) Table 241. SAMEA Immunoprecipitation (IP) Kit Sales by Type (2021-2026) & (k units) Table 242. SAMEA Immunoprecipitation (IP) Kit Sales by Type (2027-2032) & (k units) Table 243. SAMEA Immunoprecipitation (IP) Kit Sales Price by Type (2021-2026) & (US$/unit) Table 244. SAMEA Immunoprecipitation (IP) Kit Sales Price by Type (2027-2032) & (US$/unit) Table 245. SAMEA Immunoprecipitation (IP) Kit Revenue by Application (2021-2026) & (US$ Million) Table 246. SAMEA Immunoprecipitation (IP) Kit Revenue by Application (2027-2032) & (US$ Million) Table 247. SAMEA Immunoprecipitation (IP) Kit Sales by Application (2021-2026) & (k units) Table 248. SAMEA Immunoprecipitation (IP) Kit Sales by Application (2027-2032) & (k units) Table 249. SAMEA Immunoprecipitation (IP) Kit Sales Price by Application (2021-2026) & (US$/unit) Table 250. SAMEA Immunoprecipitation (IP) Kit Sales Price by Application (2027-2032) & (US$/unit) Table 251. SAMEA Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 252. SAMEA Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 253. SAMEA Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 254. SAMEA Immunoprecipitation (IP) Kit Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 255. SAMEA Immunoprecipitation (IP) Kit Sales by Country (2021-2026) & (k units) Table 256. SAMEA Immunoprecipitation (IP) Kit Sales by Country (2027-2032) & (k units) Table 257. SAMEA Immunoprecipitation (IP) Kit Sales Price by Country (2021-2026) & (US$/unit) Table 258. SAMEA Immunoprecipitation (IP) Kit Sales Price by Country (2027-2032) & (US$/unit) Table 259. Brazil Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 260. Argentina Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 261. Chile Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 262. Colombia Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 263. Peru Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 264. Saudi Arabia Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 265. Israel Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 266. UAE Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 267. Turkey Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 268. Iran Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 269. Egypt Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Table 270. Key Raw Materials Table 271. Raw Materials Key Suppliers Table 272. Immunoprecipitation (IP) Kit Distributors List Table 273. Immunoprecipitation (IP) Kit Customers List Table 274. Research Programs/Design for This Report Table 275. Authors List of This Report Table 276. Secondary Sources Table 277. Primary Sources List of Figures Figure 1. Immunoprecipitation (IP) Kit Image Figure 2. Global Immunoprecipitation (IP) Kit Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunoprecipitation (IP) Kit Market Size Share 2021 VS 2025 VS 2032 Figure 4. Protein A Image Figure 5. Protein G Image Figure 6. Global Immunoprecipitation (IP) Kit Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Immunoprecipitation (IP) Kit Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceuticals and Biotechnology Image Figure 9. Hospital and Diagnostic Laboratory Image Figure 10. Research Institute Image Figure 11. Other Image Figure 12. Global Immunoprecipitation (IP) Kit Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Immunoprecipitation (IP) Kit Revenue (2021-2032) & (US$ Million) Figure 14. Global Immunoprecipitation (IP) Kit Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Immunoprecipitation (IP) Kit Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Immunoprecipitation (IP) Kit Revenue Market Share by Region (2021-2032) Figure 17. Global Immunoprecipitation (IP) Kit Sales (2021-2032) & (k units) Figure 18. Global Immunoprecipitation (IP) Kit Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Immunoprecipitation (IP) Kit Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Immunoprecipitation (IP) Kit Sales YoY (2021-2032) & (k units) Figure 21. Europe Immunoprecipitation (IP) Kit Sales YoY (2021-2032) & (k units) Figure 22. China Immunoprecipitation (IP) Kit Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Immunoprecipitation (IP) Kit Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Immunoprecipitation (IP) Kit Sales YoY (2021-2032) & (k units) Figure 25. Global Immunoprecipitation (IP) Kit Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Immunoprecipitation (IP) Kit Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Immunoprecipitation (IP) Kit Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Immunoprecipitation (IP) Kit Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Immunoprecipitation (IP) Kit Revenue Market Share by Type (2021-2032) Figure 31. Global Immunoprecipitation (IP) Kit Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Immunoprecipitation (IP) Kit Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Immunoprecipitation (IP) Kit Sales Market Share by Type (2021-2032) Figure 34. Global Immunoprecipitation (IP) Kit Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Immunoprecipitation (IP) Kit Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Immunoprecipitation (IP) Kit Revenue Market Share by Application (2021-2032) Figure 37. Global Immunoprecipitation (IP) Kit Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Immunoprecipitation (IP) Kit Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Immunoprecipitation (IP) Kit Sales Market Share by Application (2021-2032) Figure 40. North America Immunoprecipitation (IP) Kit Revenue Share by Type (2021-2032) Figure 41. North America Immunoprecipitation (IP) Kit Sales Share by Type (2021-2032) Figure 42. North America Immunoprecipitation (IP) Kit Revenue Share by Application (2021-2032) Figure 43. North America Immunoprecipitation (IP) Kit Sales Share by Application (2021-2032) Figure 44. North America Immunoprecipitation (IP) Kit Revenue Share by Country (2021-2032) Figure 45. North America Immunoprecipitation (IP) Kit Sales Share by Country (2021-2032) Figure 46. Europe Immunoprecipitation (IP) Kit Revenue Share by Type (2021-2032) Figure 47. Europe Immunoprecipitation (IP) Kit Sales Share by Type (2021-2032) Figure 48. Europe Immunoprecipitation (IP) Kit Revenue Share by Application (2021-2032) Figure 49. Europe Immunoprecipitation (IP) Kit Sales Share by Application (2021-2032) Figure 50. Europe Immunoprecipitation (IP) Kit Revenue Share by Country (2021-2032) Figure 51. Europe Immunoprecipitation (IP) Kit Sales Share by Country (2021-2032) Figure 52. China Immunoprecipitation (IP) Kit Revenue Share by Type (2021-2032) Figure 53. China Immunoprecipitation (IP) Kit Sales Share by Type (2021-2032) Figure 54. China Immunoprecipitation (IP) Kit Revenue Share by Application (2021-2032) Figure 55. China Immunoprecipitation (IP) Kit Sales Share by Application (2021-2032) Figure 56. Asia Immunoprecipitation (IP) Kit Revenue Share by Type (2021-2032) Figure 57. Asia Immunoprecipitation (IP) Kit Sales Share by Type (2021-2032) Figure 58. Asia Immunoprecipitation (IP) Kit Revenue Share by Application (2021-2032) Figure 59. Asia Immunoprecipitation (IP) Kit Sales Share by Application (2021-2032) Figure 60. Asia Immunoprecipitation (IP) Kit Revenue Share by Country (2021-2032) Figure 61. Asia Immunoprecipitation (IP) Kit Sales Share by Country (2021-2032) Figure 62. SAMEA Immunoprecipitation (IP) Kit Revenue Share by Type (2021-2032) Figure 63. SAMEA Immunoprecipitation (IP) Kit Sales Share by Type (2021-2032) Figure 64. SAMEA Immunoprecipitation (IP) Kit Revenue Share by Application (2021-2032) Figure 65. SAMEA Immunoprecipitation (IP) Kit Sales Share by Application (2021-2032) Figure 66. SAMEA Immunoprecipitation (IP) Kit Revenue Share by Country (2021-2032) Figure 67. SAMEA Immunoprecipitation (IP) Kit Sales Share by Country (2021-2032) Figure 68. Immunoprecipitation (IP) Kit Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Immunoprecipitation (IP) Kit Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Protein A
  • Protein G
Applications
  • Pharmaceuticals and Biotechnology
  • Hospital and Diagnostic Laboratory
  • Research Institute
  • Other
Companies covered
  • Abbkine Scientific Co., Ltd.
  • Active Motif
  • CD Bioparticles
  • Cell Signaling Technology, Inc.
  • Engibody Biotechnology, Inc.
  • MyBiosource, Inc.
  • Novus Biologicals
  • Proteintech Group, Inc.
  • Rockland Immunochemicals, Inc.
  • Sino Biological, Inc.
  • Takara Bio Inc.
  • Merck KGaA
  • ACE Biotechnology
  • Thermo Fisher Scientific (China) Co., Ltd.
  • Beyotime Biotech. Inc.
  • Shanghai Epizyme Biomedical Technology Co., Ltd
  • Beaver
  • Wuhan Dia-An Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immunoprecipitation (IP) Kit Market by Type
  3. 1.2.1 Global Immunoprecipitation (IP) Kit Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Protein A
  5. 1.2.3 Protein G
  6. 1.3 Immunoprecipitation (IP) Kit Market by Application
  7. 1.3.1 Global Immunoprecipitation (IP) Kit Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceuticals and Biotechnology
  9. 1.3.3 Hospital and Diagnostic Laboratory
  10. 1.3.4 Research Institute
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Immunoprecipitation (IP) Kit Market Dynamics
  1. 2.1 Immunoprecipitation (IP) Kit Industry Trends
  2. 2.2 Immunoprecipitation (IP) Kit Industry Drivers
  3. 2.3 Immunoprecipitation (IP) Kit Industry Opportunities and Challenges
  4. 2.4 Immunoprecipitation (IP) Kit Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Immunoprecipitation (IP) Kit Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Immunoprecipitation (IP) Kit Revenue by Region
  3. 3.2.1 Global Immunoprecipitation (IP) Kit Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immunoprecipitation (IP) Kit Revenue by Region (2021-2026)
  5. 3.2.3 Global Immunoprecipitation (IP) Kit Revenue by Region (2027-2032)
  6. 3.2.4 Global Immunoprecipitation (IP) Kit Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Immunoprecipitation (IP) Kit Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Immunoprecipitation (IP) Kit Sales by Region
  9. 3.4.1 Global Immunoprecipitation (IP) Kit Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Immunoprecipitation (IP) Kit Sales by Region (2021-2026)
  11. 3.4.3 Global Immunoprecipitation (IP) Kit Sales by Region (2027-2032)
  12. 3.4.4 Global Immunoprecipitation (IP) Kit Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Immunoprecipitation (IP) Kit Revenue by Manufacturers
  2. 4.1.1 Global Immunoprecipitation (IP) Kit Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Immunoprecipitation (IP) Kit Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Immunoprecipitation (IP) Kit Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immunoprecipitation (IP) Kit Sales by Manufacturers
  6. 4.2.1 Global Immunoprecipitation (IP) Kit Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Immunoprecipitation (IP) Kit Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Immunoprecipitation (IP) Kit Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Immunoprecipitation (IP) Kit Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Immunoprecipitation (IP) Kit Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Immunoprecipitation (IP) Kit Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Immunoprecipitation (IP) Kit Manufacturers, Product Type & Application
  13. 4.7 Global Immunoprecipitation (IP) Kit Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Immunoprecipitation (IP) Kit Market CR5 and HHI
  16. 4.8.2 2025 Immunoprecipitation (IP) Kit Tier 1, Tier 2, and Tier 3
5 Immunoprecipitation (IP) Kit Market by Type
  1. 5.1 Global Immunoprecipitation (IP) Kit Revenue by Type
  2. 5.1.1 Global Immunoprecipitation (IP) Kit Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Immunoprecipitation (IP) Kit Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Immunoprecipitation (IP) Kit Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Immunoprecipitation (IP) Kit Sales by Type
  6. 5.2.1 Global Immunoprecipitation (IP) Kit Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immunoprecipitation (IP) Kit Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Immunoprecipitation (IP) Kit Sales Market Share by Type (2021-2032)
  9. 5.3 Global Immunoprecipitation (IP) Kit Price by Type
6 Immunoprecipitation (IP) Kit Market by Application
  1. 6.1 Global Immunoprecipitation (IP) Kit Revenue by Application
  2. 6.1.1 Global Immunoprecipitation (IP) Kit Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Immunoprecipitation (IP) Kit Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Immunoprecipitation (IP) Kit Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Immunoprecipitation (IP) Kit Sales by Application
  6. 6.2.1 Global Immunoprecipitation (IP) Kit Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Immunoprecipitation (IP) Kit Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Immunoprecipitation (IP) Kit Sales Market Share by Application (2021-2032)
  9. 6.3 Global Immunoprecipitation (IP) Kit Price by Application
7 Company Profiles
  1. 7.1 Abbkine Scientific Co., Ltd.
  2. 7.1.1 Abbkine Scientific Co., Ltd. Company Information
  3. 7.1.2 Abbkine Scientific Co., Ltd. Business Overview
  4. 7.1.3 Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbkine Scientific Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio
  6. 7.1.5 Abbkine Scientific Co., Ltd. Recent Developments
  7. 7.2 Active Motif
  8. 7.2.1 Active Motif Company Information
  9. 7.2.2 Active Motif Business Overview
  10. 7.2.3 Active Motif Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Active Motif Immunoprecipitation (IP) Kit Product Portfolio
  12. 7.2.5 Active Motif Recent Developments
  13. 7.3 CD Bioparticles
  14. 7.3.1 CD Bioparticles Company Information
  15. 7.3.2 CD Bioparticles Business Overview
  16. 7.3.3 CD Bioparticles Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CD Bioparticles Immunoprecipitation (IP) Kit Product Portfolio
  18. 7.3.5 CD Bioparticles Recent Developments
  19. 7.4 Cell Signaling Technology, Inc.
  20. 7.4.1 Cell Signaling Technology, Inc. Company Information
  21. 7.4.2 Cell Signaling Technology, Inc. Business Overview
  22. 7.4.3 Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cell Signaling Technology, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  24. 7.4.5 Cell Signaling Technology, Inc. Recent Developments
  25. 7.5 Engibody Biotechnology, Inc.
  26. 7.5.1 Engibody Biotechnology, Inc. Company Information
  27. 7.5.2 Engibody Biotechnology, Inc. Business Overview
  28. 7.5.3 Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Engibody Biotechnology, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  30. 7.5.5 Engibody Biotechnology, Inc. Recent Developments
  31. 7.6 MyBiosource, Inc.
  32. 7.6.1 MyBiosource, Inc. Company Information
  33. 7.6.2 MyBiosource, Inc. Business Overview
  34. 7.6.3 MyBiosource, Inc. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 MyBiosource, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  36. 7.6.5 MyBiosource, Inc. Recent Developments
  37. 7.7 Novus Biologicals
  38. 7.7.1 Novus Biologicals Company Information
  39. 7.7.2 Novus Biologicals Business Overview
  40. 7.7.3 Novus Biologicals Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Novus Biologicals Immunoprecipitation (IP) Kit Product Portfolio
  42. 7.7.5 Novus Biologicals Recent Developments
  43. 7.8 Proteintech Group, Inc.
  44. 7.8.1 Proteintech Group, Inc. Company Information
  45. 7.8.2 Proteintech Group, Inc. Business Overview
  46. 7.8.3 Proteintech Group, Inc. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Proteintech Group, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  48. 7.8.5 Proteintech Group, Inc. Recent Developments
  49. 7.9 Rockland Immunochemicals, Inc.
  50. 7.9.1 Rockland Immunochemicals, Inc. Company Information
  51. 7.9.2 Rockland Immunochemicals, Inc. Business Overview
  52. 7.9.3 Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Rockland Immunochemicals, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  54. 7.9.5 Rockland Immunochemicals, Inc. Recent Developments
  55. 7.10 Sino Biological, Inc.
  56. 7.10.1 Sino Biological, Inc. Company Information
  57. 7.10.2 Sino Biological, Inc. Business Overview
  58. 7.10.3 Sino Biological, Inc. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sino Biological, Inc. Immunoprecipitation (IP) Kit Product Portfolio
  60. 7.10.5 Sino Biological, Inc. Recent Developments
  61. 7.11 Takara Bio Inc.
  62. 7.11.1 Takara Bio Inc. Company Information
  63. 7.11.2 Takara Bio Inc. Business Overview
  64. 7.11.3 Takara Bio Inc. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Takara Bio Inc. Immunoprecipitation (IP) Kit Product Portfolio
  66. 7.11.5 Takara Bio Inc. Recent Developments
  67. 7.12 Merck KGaA
  68. 7.12.1 Merck KGaA Company Information
  69. 7.12.2 Merck KGaA Business Overview
  70. 7.12.3 Merck KGaA Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Merck KGaA Immunoprecipitation (IP) Kit Product Portfolio
  72. 7.12.5 Merck KGaA Recent Developments
  73. 7.13 ACE Biotechnology
  74. 7.13.1 ACE Biotechnology Company Information
  75. 7.13.2 ACE Biotechnology Business Overview
  76. 7.13.3 ACE Biotechnology Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 ACE Biotechnology Immunoprecipitation (IP) Kit Product Portfolio
  78. 7.13.5 ACE Biotechnology Recent Developments
  79. 7.14 Thermo Fisher Scientific (China) Co., Ltd.
  80. 7.14.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
  81. 7.14.2 Thermo Fisher Scientific (China) Co., Ltd. Business Overview
  82. 7.14.3 Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Thermo Fisher Scientific (China) Co., Ltd. Immunoprecipitation (IP) Kit Product Portfolio
  84. 7.14.5 Thermo Fisher Scientific (China) Co., Ltd. Recent Developments
  85. 7.15 Beyotime Biotech. Inc.
  86. 7.15.1 Beyotime Biotech. Inc. Company Information
  87. 7.15.2 Beyotime Biotech. Inc. Business Overview
  88. 7.15.3 Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Beyotime Biotech. Inc. Immunoprecipitation (IP) Kit Product Portfolio
  90. 7.15.5 Beyotime Biotech. Inc. Recent Developments
  91. 7.16 Shanghai Epizyme Biomedical Technology Co., Ltd
  92. 7.16.1 Shanghai Epizyme Biomedical Technology Co., Ltd Company Information
  93. 7.16.2 Shanghai Epizyme Biomedical Technology Co., Ltd Business Overview
  94. 7.16.3 Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Shanghai Epizyme Biomedical Technology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio
  96. 7.16.5 Shanghai Epizyme Biomedical Technology Co., Ltd Recent Developments
  97. 7.17 Beaver
  98. 7.17.1 Beaver Company Information
  99. 7.17.2 Beaver Business Overview
  100. 7.17.3 Beaver Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Beaver Immunoprecipitation (IP) Kit Product Portfolio
  102. 7.17.5 Beaver Recent Developments
  103. 7.18 Wuhan Dia-An Biotechnology Co., Ltd
  104. 7.18.1 Wuhan Dia-An Biotechnology Co., Ltd Company Information
  105. 7.18.2 Wuhan Dia-An Biotechnology Co., Ltd Business Overview
  106. 7.18.3 Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Wuhan Dia-An Biotechnology Co., Ltd Immunoprecipitation (IP) Kit Product Portfolio
  108. 7.18.5 Wuhan Dia-An Biotechnology Co., Ltd Recent Developments
8 North America
  1. 8.1 North America Immunoprecipitation (IP) Kit Market Size by Type
  2. 8.1.1 North America Immunoprecipitation (IP) Kit Revenue by Type (2021-2032)
  3. 8.1.2 North America Immunoprecipitation (IP) Kit Sales by Type (2021-2032)
  4. 8.1.3 North America Immunoprecipitation (IP) Kit Price by Type (2021-2032)
  5. 8.2 North America Immunoprecipitation (IP) Kit Market Size by Application
  6. 8.2.1 North America Immunoprecipitation (IP) Kit Revenue by Application (2021-2032)
  7. 8.2.2 North America Immunoprecipitation (IP) Kit Sales by Application (2021-2032)
  8. 8.2.3 North America Immunoprecipitation (IP) Kit Price by Application (2021-2032)
  9. 8.3 North America Immunoprecipitation (IP) Kit Market Size by Country
  10. 8.3.1 North America Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Immunoprecipitation (IP) Kit Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Immunoprecipitation (IP) Kit Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Immunoprecipitation (IP) Kit Market Size by Type
  2. 9.1.1 Europe Immunoprecipitation (IP) Kit Revenue by Type (2021-2032)
  3. 9.1.2 Europe Immunoprecipitation (IP) Kit Sales by Type (2021-2032)
  4. 9.1.3 Europe Immunoprecipitation (IP) Kit Price by Type (2021-2032)
  5. 9.2 Europe Immunoprecipitation (IP) Kit Market Size by Application
  6. 9.2.1 Europe Immunoprecipitation (IP) Kit Revenue by Application (2021-2032)
  7. 9.2.2 Europe Immunoprecipitation (IP) Kit Sales by Application (2021-2032)
  8. 9.2.3 Europe Immunoprecipitation (IP) Kit Price by Application (2021-2032)
  9. 9.3 Europe Immunoprecipitation (IP) Kit Market Size by Country
  10. 9.3.1 Europe Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Immunoprecipitation (IP) Kit Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Immunoprecipitation (IP) Kit Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Immunoprecipitation (IP) Kit Market Size by Type
  2. 10.1.1 China Immunoprecipitation (IP) Kit Revenue by Type (2021-2032)
  3. 10.1.2 China Immunoprecipitation (IP) Kit Sales by Type (2021-2032)
  4. 10.1.3 China Immunoprecipitation (IP) Kit Price by Type (2021-2032)
  5. 10.2 China Immunoprecipitation (IP) Kit Market Size by Application
  6. 10.2.1 China Immunoprecipitation (IP) Kit Revenue by Application (2021-2032)
  7. 10.2.2 China Immunoprecipitation (IP) Kit Sales by Application (2021-2032)
  8. 10.2.3 China Immunoprecipitation (IP) Kit Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immunoprecipitation (IP) Kit Market Size by Type
  2. 11.1.1 Asia Immunoprecipitation (IP) Kit Revenue by Type (2021-2032)
  3. 11.1.2 Asia Immunoprecipitation (IP) Kit Sales by Type (2021-2032)
  4. 11.1.3 Asia Immunoprecipitation (IP) Kit Price by Type (2021-2032)
  5. 11.2 Asia Immunoprecipitation (IP) Kit Market Size by Application
  6. 11.2.1 Asia Immunoprecipitation (IP) Kit Revenue by Application (2021-2032)
  7. 11.2.2 Asia Immunoprecipitation (IP) Kit Sales by Application (2021-2032)
  8. 11.2.3 Asia Immunoprecipitation (IP) Kit Price by Application (2021-2032)
  9. 11.3 Asia Immunoprecipitation (IP) Kit Market Size by Country
  10. 11.3.1 Asia Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Immunoprecipitation (IP) Kit Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Immunoprecipitation (IP) Kit Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immunoprecipitation (IP) Kit Market Size by Type
  2. 12.1.1 SAMEA Immunoprecipitation (IP) Kit Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Immunoprecipitation (IP) Kit Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Immunoprecipitation (IP) Kit Price by Type (2021-2032)
  5. 12.2 SAMEA Immunoprecipitation (IP) Kit Market Size by Application
  6. 12.2.1 SAMEA Immunoprecipitation (IP) Kit Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Immunoprecipitation (IP) Kit Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Immunoprecipitation (IP) Kit Price by Application (2021-2032)
  9. 12.3 SAMEA Immunoprecipitation (IP) Kit Market Size by Country
  10. 12.3.1 SAMEA Immunoprecipitation (IP) Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Immunoprecipitation (IP) Kit Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Immunoprecipitation (IP) Kit Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Immunoprecipitation (IP) Kit Value Chain Analysis
  2. 13.1.1 Immunoprecipitation (IP) Kit Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Immunoprecipitation (IP) Kit Production Mode & Process
  6. 13.2 Immunoprecipitation (IP) Kit Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Immunoprecipitation (IP) Kit Distributors
  9. 13.2.3 Immunoprecipitation (IP) Kit Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst